VIMOVO | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

VIMOVO
Canada

PharmaCompass Sponsored Ads

Contact Supplier

Granules Esomeprazole Magnesium

Contact Supplier

Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Contact Supplier

Temad- We think of world-class quality.

Contact Supplier

VIMOVO

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

209 API Suppliers, 66 USDMF, 50 CEP/COS, 7 JDMF, 49 EU WC, 83 KDMF, 47 NDC API, 66 Listed Suppliers, $ API Reference Price

209 API Suppliers
66 USDMF
50 CEP/COS
7 JDMF
49 EU WC
83 KDMF
47 NDC API
66 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

101 Drugs in Development

101 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

873 FDF Dossiers, 105 FDA Orange Book, 317 Europe, 23 Canada, 145 Australia, 68 South Africa, 215 Listed Dossiers

873 FDF Dossiers
105 FDA Orange Book
317 Europe
23 Canada
145 Australia
68 South Africa
215 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 7 Evonik, 1 Rochem International Inc, 18 SPI Pharma, 10 DKSH, 3 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 30 BASF, 2 CD Formulation, 15 Corel Pharma Chem, 3 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 12 Ideal Cures, 4 Ingredion Pharma Solutions, 11 Kerry, 2 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 66 Coating Systems & Additives, 39 Controlled & Modified Release, 34 Solubilizers, 33 Thickeners and Stabilizers, 29 Direct Compression, 27 Taste Masking, 25 Granulation, 23 Disintegrants & Superdisintegrants, 21 Lubricants & Glidants, 19 Chewable & Orodispersible Aids, 18 Topical, 18 Film Formers & Plasticizers, 16 Parenteral, 14 Co-Processed Excipients, 10 Emulsifying Agents, 9 Empty Capsules, 6 Rheology Modifiers, 6 Surfactant & Foaming Agents, 5 Coloring Agents, 5 API Stability Enhancers, 4 Vegetarian Capsules

67 Fillers, Diluents & Binders
66 Coating Systems & Additives
39 Controlled & Modified Release
34 Solubilizers
33 Thickeners and Stabilizers
29 Direct Compression
27 Taste Masking
25 Granulation
23 Disintegrants & Superdisintegrants
21 Lubricants & Glidants
19 Chewable & Orodispersible Aids
18 Topical
18 Film Formers & Plasticizers
16 Parenteral
14 Co-Processed Excipients
10 Emulsifying Agents
9 Empty Capsules
6 Rheology Modifiers
6 Surfactant & Foaming Agents
5 Coloring Agents
5 API Stability Enhancers
4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 154 News #PharmaBuzz

1 Data Compilation #PharmaFlow
154 News #PharmaBuzz

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions, 243 Regulatory FDF Prices, 18 Annual Reports

23 US Medicaid Prescriptions
243 Regulatory FDF Prices
18 Annual Reports

MARKET PLACE

68 APIs, 36 FDF Dossiers

68 APIs
36 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 40 Health Canada Patents

2 US Patents
40 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 1 USP, 21 Others

5 EDQM
1 USP
21 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 195 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

23 All

01 2APOTEX INC

02 3ASTRAZENECA CANADA INC

03 1HALEON CANADA ULC

04 2JAMP PHARMA CORPORATION

05 2MANTRA PHARMA INC

06 4MYLAN PHARMACEUTICALS ULC

07 2PRO DOC LIMITEE

08 1Pharmascience Inc.

09 2SIVEM PHARMACEUTICALS ULC

10 2SUN PHARMA CANADA INC

11 2XEDITON PHARMACEUTICALS INC

filter Active Ingredients Reset all filters

23 All

01 8ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)

02 14ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM)

03 1Esomeprazole Magnesium

filter Dosage Form Reset all filters

23 All

01 2CAPSULE (DELAYED RELEASE)

02 1GRANULES FOR SUSPENSION, DELAYED RELEASE

03 16TABLET (DELAYED-RELEASE)

04 4TABLET (IMMEDIATE AND DELAYED-RELEASE)

filter Brand Name Reset all filters

23 All

01 2APO-ESOMEPRAZOLE

02 6ESOMEPRAZOLE

03 2M-ESOMEPRAZOLE

04 2MYL-ESOMEPRAZOLE

05 2MYLAN-NAPROXEN/ESOMEPRAZOLE MR

06 1NEXIUM

07 1NEXIUM - 20MG

08 1NEXIUM - 40MG

09 1NEXIUM 24HR

10 1PMS-ESOMEPRAZOLE DR

11 2TARO-ESOMEPRAZOLE

12 2VIMOVO

Esomeprazole Magnesium

List of Suppliers

Product Main Page

01

APOTEX INC

The MedTech Conference

Not Confirmed

APOTEX INC

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM)

Brand Name : APO-ESOMEPRAZOLE

Dosage Form : TABLET (DELAYED-RELEASE)

Dosage Strength : 20MG

Packaging : 30/100

Approval Date :

Application Number : 2339099

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

APOTEX INC

The MedTech Conference

Not Confirmed

APOTEX INC

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM)

Brand Name : APO-ESOMEPRAZOLE

Dosage Form : TABLET (DELAYED-RELEASE)

Dosage Strength : 40MG

Packaging : 28/100/500

Approval Date :

Application Number : 2339102

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ASTRAZENECA CANADA INC

The MedTech Conference

Not Confirmed

ASTRAZENECA CANADA INC

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)

Brand Name : NEXIUM - 20MG

Dosage Form : TABLET (DELAYED-RELEASE)

Dosage Strength : 20MG

Packaging : 14/28/100

Approval Date :

Application Number : 2244521

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ASTRAZENECA CANADA INC

The MedTech Conference

Not Confirmed

ASTRAZENECA CANADA INC

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)

Brand Name : NEXIUM - 40MG

Dosage Form : TABLET (DELAYED-RELEASE)

Dosage Strength : 40MG

Packaging : 7/14/28/56/100

Approval Date :

Application Number : 2244522

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

ASTRAZENECA CANADA INC

The MedTech Conference

Not Confirmed

ASTRAZENECA CANADA INC

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)

Brand Name : NEXIUM

Dosage Form : GRANULES FOR SUSPENSION, DELAYED RELEASE

Dosage Strength : 10MG/SACHET

Packaging : 28

Approval Date :

Application Number : 2300524

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Pharmascience Inc.

The MedTech Conference

Not Confirmed

Pharmascience Inc.

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Esomeprazole Magnesium

Brand Name : PMS-ESOMEPRAZOLE DR

Dosage Form : CAPSULE (DELAYED RELEASE)

Dosage Strength : 40MG

Packaging : 30/100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

PRO DOC LIMITEE

The MedTech Conference

Not Confirmed

PRO DOC LIMITEE

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM)

Brand Name : ESOMEPRAZOLE

Dosage Form : TABLET (DELAYED-RELEASE)

Dosage Strength : 20MG

Packaging : 30/100

Approval Date :

Application Number : 2394839

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

PRO DOC LIMITEE

The MedTech Conference

Not Confirmed

PRO DOC LIMITEE

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM)

Brand Name : ESOMEPRAZOLE

Dosage Form : TABLET (DELAYED-RELEASE)

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 2394847

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

XEDITON PHARMACEUTICALS INC

The MedTech Conference

Not Confirmed

XEDITON PHARMACEUTICALS INC

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)

Brand Name : VIMOVO

Dosage Form : TABLET (IMMEDIATE AND DELAYED-RELEASE)

Dosage Strength : 20MG

Packaging : 60

Approval Date :

Application Number : 2361701

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

XEDITON PHARMACEUTICALS INC

The MedTech Conference

Not Confirmed

XEDITON PHARMACEUTICALS INC

The MedTech Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)

Brand Name : VIMOVO

Dosage Form : TABLET (IMMEDIATE AND DELAYED-RELEASE)

Dosage Strength : 20MG

Packaging : Aug-60

Approval Date :

Application Number : 2361728

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!